The world's largest beauty company is said to have emerged as the front-runner to buy the U.K.-based skin care brand.

Conference Call and Webcast Today at 8:30 a.m. ET OCU400 Phase 3 clinical trial for retinitis pigmentosa (RP) is progressing well and on target for potential BLA/MAA filings by mid-2026Anticipate init ...